Lantz Financial’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.7M | Buy |
18,566
+95
| +0.5% | +$8.31K | 0.31% | 88 |
|
|
2026
Q1 | $1.57M | Sell |
18,471
-883
| -5% | -$78.7K | 0.33% | 83 |
|
|
2025
Q4 | $1.53M | Buy |
19,354
+149
| +0.8% | +$11.7K | 0.32% | 85 |
|
|
2025
Q3 | $1.54M | Buy |
19,205
+3
| +0% | +$256 | 0.34% | 85 |
|
|
2025
Q2 | $1.75M | Sell |
19,202
-83
| -0.4% | -$7.58K | 0.44% | 70 |
|
|
2025
Q1 | $1.81M | Sell |
19,285
-855
| -4% | -$76.6K | 0.49% | 60 |
|
|
2024
Q4 | $1.83M | Buy |
20,140
+122
| +0.6% | +$11.6K | 0.49% | 60 |
|
|
2024
Q3 | $2.08M | Buy |
20,018
+24
| +0.1% | +$2.45K | 0.56% | 54 |
|
|
2024
Q2 | $1.94M | Sell |
19,994
-56
| -0.3% | -$5.17K | 0.6% | 49 |
|
|
2024
Q1 | $1.81M | Buy |
20,050
+135
| +0.7% | +$11.4K | 0.58% | 54 |
|
|
2023
Q4 | $1.59M | Buy |
19,915
+801
| +4% | +$60.2K | 0.57% | 51 |
|
|
2023
Q3 | $1.36M | Sell |
19,114
-292
| -2% | -$21.8K | 0.54% | 54 |
|
|
2023
Q2 | $1.5M | Sell |
19,406
-38
| -0.2% | -$2.94K | 0.59% | 53 |
|
|
2023
Q1 | $1.46M | Sell |
19,444
-145
| -0.7% | -$10.8K | 0.61% | 50 |
|
|
2022
Q4 | $1.54M | Buy |
19,589
+317
| +2% | +$23.8K | 0.7% | 39 |
|
|
2022
Q3 | $1.35M | Buy |
19,272
+58
| +0.3% | +$4.55K | 0.7% | 39 |
|
|
2022
Q2 | $1.54M | Buy |
19,214
+75
| +0.4% | +$5.87K | 0.7% | 40 |
|
|
2022
Q1 | $1.45M | Buy |
19,139
+287
| +2% | +$22.7K | 0.59% | 52 |
|
|
2021
Q4 | $1.61M | Buy |
18,852
+778
| +4% | +$60.8K | 0.74% | 40 |
|
|
2021
Q3 | $1.37M | Buy |
18,074
+378
| +2% | +$30K | 0.7% | 43 |
|
|
2021
Q2 | $1.44M | Buy |
17,696
+27
| +0.2% | +$2.21K | 0.74% | 40 |
|
|
2021
Q1 | $1.39M | Buy |
17,669
+125
| +0.7% | +$9.8K | 0.79% | 38 |
|
|
2020
Q4 | $1.5M | Sell |
17,544
-268
| -2% | -$22.2K | 0.94% | 29 |
|
|
2020
Q3 | $1.37M | Sell |
17,812
-31
| -0.2% | -$2.36K | 0.92% | 33 |
|
|
2020
Q2 | $1.31M | Sell |
17,843
-425
| -2% | -$30.2K | 0.94% | 31 |
|
|
2020
Q1 | $1.21M | Sell |
18,268
-827
| -4% | -$58.3K | 0.95% | 31 |
|
|
2019
Q4 | $1.31M | Buy |
19,095
+220
| +1% | +$15K | 0.78% | 47 |
|
|
2019
Q3 | $1.33M | Buy |
18,875
+213
| +1% | +$15.5K | 0.9% | 36 |
|
|
2019
Q2 | $1.36M | Buy |
18,662
+436
| +2% | +$31K | 0.92% | 36 |
|
|
2019
Q1 | $1.25M | Buy |
+18,226
| New | +$1.18M | 0.91% | 39 |
|
Other funds holding CL
Lantz Financial's CL Position: Q2 2026 in Review
Lantz Financial increased its Colgate-Palmolive (CL) stake by 0.51% in Q2 2026, buying an estimated $8.31K and bringing the position to 18,566 shares worth $1.7M. The position accounts for 0.31% of the portfolio, ranked #88.
Lantz Financial first reported a position in CL in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.08M in Q3 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Lantz Financial held 18,566 shares of Colgate-Palmolive worth $1.7M as of Q2 2026.
- Lantz Financial bought 95 Colgate-Palmolive shares in Q2 2026, an estimated $8.31K.
- Colgate-Palmolive made up 0.31% of Lantz Financial's portfolio in Q2 2026, its #88 holding.
- Lantz Financial first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 30 quarters since.
- Lantz Financial's Colgate-Palmolive position peaked at $2.08M in Q3 2024.
- 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.